Insights

How to Run Country Feasibility for a Multi-Country Trial

Country feasibility answers one question: where can this protocol be delivered on time with the patients it needs. A structured approach keeps the decision objective.

What feasibility should cover

  • Patient availability, local standard of care and how it compares with the protocol.
  • Investigator interest, experience and capacity at each candidate site.
  • Competing studies in the same indication and their effect on recruitment.
  • Regulatory and ethics route, translation needs and investigational product logistics.

Data to collect from sites

  • Number of eligible patients seen per year, and how patients would be identified.
  • Equipment, laboratory and pharmacy capabilities needed for the protocol.
  • Staffing, other ongoing trials and the time needed for contracts and approvals.

How to compare countries

  • Score countries on the same criteria, and weigh each criterion according to your protocol.
  • Combine countries with different strengths, for example EU countries using CTIS and non-EU countries with national procedures, to spread risk.
  • Revisit the plan if enrolment lags, and add or replace sites early.

Common mistakes

  • Using optimistic enrolment estimates from a single investigator.
  • Ignoring competing trials or seasonal effects.
  • Leaving import, labelling and storage questions until after approval.

Discuss your study

Share your protocol synopsis and target countries, and we will respond with a feasibility view.

Request a proposal Contact us

Related reading

Last reviewed 1 October 2026. This is general information, not regulatory or legal advice. Requirements change, so confirm current rules for your protocol.